Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial (Q42995489)

12 November 2017

Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial (English)

1 reference

12 November 2017

1 reference

M P Look

1

1 reference

12 November 2017

A Gerard

2

1 reference

12 November 2017

G S Rao

3

1 reference

12 November 2017

T Sudhop

4

1 reference

12 November 2017

H P Fischer

5

1 reference

12 November 2017

T Sauerbruch

6

1 reference

12 November 2017

U Spengler

7

1 reference

12 November 2017

1 September 1999

1 reference

12 November 2017

1 reference

12 November 2017

43

1 reference

12 November 2017

113-122

1 reference

12 November 2017

2

1 reference

Vitamin E for chronic hepatitis B.

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Time course of total cysteine, glutathione and homocysteine in plasma of patients with chronic hepatitis C treated with interferon-alpha with and without supplementation with N-acetylcysteine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Association between reactive oxygen species and disease activity in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Excess iron induces hepatic oxidative stress and transforming growth factor beta1 in genetic hemochromatosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Selenium and immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Plasma glutathione concentration in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Vitamin E status in patients with liver cirrhosis: normal or deficient?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

1 reference

7 January 2021

A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

A model to predict long-term sustained response to interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Oxidative damage and fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

1 reference

7 January 2021

Selenium: Biochemical Role as a Component of Glutathione Peroxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

1 reference

7 January 2021

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

44 Glutathione peroxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900041-8

7 January 2021

10.1016/S0166-3542(99)00041-8

Identifiers

DOI

1 reference

12 November 2017

1 reference